Aditya Birla Sun Life Pharma & Healthcare Fund Regular Payout Inc Dist cum Cap Wdrl
EquitySector - Healthcare
21.76
0.19(0.88%)
NAV as on 02 Jan, 2026
CAGR
21.56%
- AUM (Crs.)853.63
- Expense Ratio2.30 %
- Sharpe Ratio / Category Average0.89 / 0.94
- Standard Deviation / Category Average15.82 / 16.00
- Beta / Category Average0.96 / 0.96
- Portfolio Turnover / Category Average23.28 / 35.03
- Top 5 Stocks Wt.35.87
- Top 10 Stocks Wt.56.77
- Top 3 Sectors Wt.97.67
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocks--
- Avg. Market Cap--
- Top 10 Stocks--
- Top 5 Stocks--
- Top 3 Sectors--
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistoryDhaval Shah
- Launch Date11 Jul, 2019
- BenchmarkS&P BSE 500
Objective
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|